Handan Kekec

Dr. Handan Kekec

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2026 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
HKHandan Kekec
Handan Kekec
AAAyse Tana Aslan
Ayse Tana Aslan
AAAyse Tana Aslan
Ayse Tana Aslan
OUOzge Ulgen
Ozge Ulgen
AOAslıhan Ozcaglar
Aslıhan Ozcaglar
NKNural Kiper
Nural Kiper
Childhood interstitial lung diseases (chILD) include a diverse range of rare disorders, complex clinical progressions, and high rates of morbidity and mortality. This study aims to assess the clinical and psychosocial impacts of chILD in children registered in the National chILD-Turkiye database. Data from 17 centers were analyzed as of January 2024. Patients aged 1 month to 18 years were included in the study. Through face-to-face interviews, patients and their families completed the Pediatric Quality of Life Inventory (PedsQL™ 4.0 Generic Core Scales) and PedsQL™ 2.0 Family Impact Module. Higher scores suggest better performance and higher health-related quality of life (HRQoL). Patient clinic data, demographic information, pulmonary function tests, Fan scores, and household income were recorded. Patients were categorized into two groups according to their use of O 2 therapy and diffuse progressive lung disease (DPLD) groups A and B. The study included 175 patients (90 girls), with a median age of 7.7 (1.0–17.8) years. A strong positive correlation was found between the FEV1% value and both the Physical Health Summary Score and the Total Score ( p = 0.007, r = 0.608; p = 0.008, r = 0.607). The Fan score negatively correlated with PedsQL™ scores ( p < 0.001). Patients who use O 2 have an earlier diagnosis of age of chILD, lower FEV1%, higher Fan scores, and lower Child Self-Reports and Parent Reports scores ( p < 0.05). The group with DPLD-A disorders has an earlier diagnosis age, lower weight and BMI z-scores, higher Fan score, and higher Family Impact Module score ( p < 0.05). Conclusion : Lung function and Fan score strongly correlate with HRQoL, emphasizing the impact of disease severity on physical and psychosocial well-being. These findings highlight the need for multidisciplinary care and psychosocial support to enhance the QoL in children with chILD and their families. What is Known: • Childhood interstitial lung diseases (chILD) are rare and diverse disorders associated with significant morbidity and complex management. • Evidence regarding health-related quality of life (HRQoL) and the psychosocial burden on affected families remains limited. What is New: • This multicenter national registry–based study provides the first comprehensive evaluation of HRQoL and family impact in children with chILD in Türkiye. • Lung function impairment and higher Fan severity scores were strongly linked to poorerHRQoL, highlighting the influence of disease severity on physical and psychosocial well-being.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
HKHandan Kekec
Handan Kekec
TETuğba Şişmanlar Eyüboğlu
Tuğba Şişmanlar Eyüboğlu
PAPelin Asfuroğlu
Pelin Asfuroğlu
ZHZeynep İlkşen Hocoğlu
Zeynep İlkşen Hocoğlu
EÇEylül Pınar Çakır
Eylül Pınar Çakır
AAAyşe Tana Aslan
Ayşe Tana Aslan
Background: This study aimed to assess long-term clinical outcomes in children with COVID-19. Method: All children presenting to the pediatric pulmonology clinic between March 2020 and July 2022 with confirmed COVID-19 were included the study. Demographic, clinical and laboratory data were retrospectively recorded. Short and long-term outcomes were compared. Results: 151 patients were analyzed. Median age was 108 (60-159) months, with 52.3% females. 81.5% had underlying disease. Fever, cough, weakness, sore throat, and shortness of breath were common during COVID-19. 28 patients required hospitalization, with 9 in pediatric intensive care and 23 needing oxygen. 22 hospitalized patients had underlying disease. MISC occurred in 4 patients, with no fatalities. Long COVID symptoms were reported by 48 patients, notably cough (56.3%), shortness of breath (45.8%), sputum (29.2%), chest pain (27.1%) and effort limitation (27.1%). 34 patients underwent PFTs, median FEV1 was 103% (94,5-113), FVC 101% (87,5-110) FEV1/FVC 106% (101,5-110,5). Children without underlying disease showed more Long COVID presentations (p=0.022). In patients with Long COVID, those with fewer than 5 symptoms during the acute COVID-19 phase compared to individuals with 5 or more symptoms exhibited a higher frequency of shortness of breath, exertional limitation and chest pain (p<0.05). Conclusion: Despite mild acute symptoms, severe clinical conditions can manifest in pediatric COVID-19 cases. It was thought that children with chronic diseases had fewer Long COVID complaints may have associated the symptoms they experienced with their own chronic disease. Approximately one-third of patients remained symptomatic, necessitating monitoring for Long COVID.

14 September 2024
Verified
Conference Paper
Closed access
HKHandan Kekec
Handan Kekec
TETuğba Şişmanlar Eyüboğlu
Tuğba Şişmanlar Eyüboğlu
AAAyse Tana Aslan
Ayse Tana Aslan
VMVolkan Medeni
Volkan Medeni
BÇBahar Çuhacı Çakır
Bahar Çuhacı Çakır
Introduction: Immunoreactive trypsinogen (IRT) is utilized in newborn screening for cystic fibrosis(CF). This study aims to investigate factors affecting IRT levels. Methods: Children admitted with elevated IRT levels at the pediatric pulmonology department between January 01, 2023-2024, were included. The control group comprised healthy children randomly selected from the outpatient pediatric department with normal IRT levels. Demographic and clinical data of Case(Group1) and Control Group(Group2) were retrospectively recorded and compared. Results: 76 children were included in Group1 and 77 in Group2. Median age at Group1 was 23.5 days, with 56.6% females. Three patients in Group1 had CF diagnosis. No difference between the groups in terms of age, gender and height z score (p>0.05). The mean weight z score of Group1 (−0.32±0.87) was lower than Group2 (p=0.031). Maternal smoking exposure during pregnancy, maternal chronic diseases, maternal parity and being the third or later-born child were higher in Group1 (p <0.05). In Group2 the number of babies with a birth weight over 4000 grams and a gestational age over 41 weeks was higher(p 0.05). Discussion:It may be recommended to increase the cut-off value for IRT/IRT in newborns with low birth weight, who were exposed to maternal smoking during pregnancy, whose mothers have a chronic disease and a history of three or more pregnancies. Larger studies will provide clearer insights into these associations

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
HKHandan Kekec
Handan Kekec
YDYasemin Duman
Yasemin Duman
TETuğba Şişmanlar Eyüboğlu
Tuğba Şişmanlar Eyüboğlu
AAAyşe Tana Aslan
Ayşe Tana Aslan
MYMerve Yazol
Merve Yazol
VMVolkan Medeni
Volkan Medeni
Introduction: It was aimed to evaluate the clinical features of cystic fibrosis(CF) and non-CF bronchiectasis(BE) in children Method: Between 2006 and 2023, all patients aged 0-18 years admitted with BE detected on CT were included. Data were retrospectively recorded. BE severity was scored according to the total Bhalla score(TBS) as mild, moderate, or severe. Results: 157 patients were included, 51% were female. The most common etiologies were CF, post-infectious, immunodeficiency, primary ciliary dyskinesia, and others. In CF (Group1), patients had lower initial visit age, height, BMI z-score compared to non-CF (Group 2)(p 0.05). There was an increase in final height, weight and BMI z-scores compared to the initial visit in Group 1 (p0.05). In Group 1, the mean age at the first visit was younger and follow-up period was longer (p <0.05). No difference between the groups was found in mean diagnosis age, final visit FEV1, and FVC values. According to the TBS 27.0% of Group 1 were classified as mild, 37.8% moderate, and 35.1% severe, while in Group 2, 61.7% were mild, 33.3% moderate, and 5% severe. Severe scores were more common in Group1 (p <0.001). There was a positive correlation between TBS and initial and final visit height, weight, and BMI z-scores, final FEV1, FVC(p <0.05). Discussion: Although severe scores were more common in CF, no difference in final spirometry parameters between CF and non-CF patients suggests that the increase in follow-up height, weight, and BMI z-scores may be due to earlier monitoring and longer follow-up. Spirometry and growth z-scores were associated with radiological scores.